Selected article for: "DM high prevalence and DM prevalence"

Author: da Cunha, Gilmara Franco; de Souza, Fernando Henrique Carlos; Levy-Neto, Maurício; Shinjo, Samuel Katsuyuki
Title: Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
  • Document date: 2013_5_23
  • ID: s9mqzqu4_30
    Snippet: In conclusion, our data showed a high prevalence of HZ in the DM/PM population studied and confirmed that chloroquine diphosphate is a risk factor for HZ development in this population, particularly women and DM patients. Further research is necessary to evaluate the possible molecular mechanism underlying the higher HZ prevalence in DM subjects compared to PM patient populations......
    Document: In conclusion, our data showed a high prevalence of HZ in the DM/PM population studied and confirmed that chloroquine diphosphate is a risk factor for HZ development in this population, particularly women and DM patients. Further research is necessary to evaluate the possible molecular mechanism underlying the higher HZ prevalence in DM subjects compared to PM patient populations.

    Search related documents:
    Co phrase search for related documents
    • chloroquine diphosphate and HZ development: 1
    • chloroquine diphosphate and HZ high prevalence: 1
    • chloroquine diphosphate and HZ prevalence: 1
    • chloroquine diphosphate and risk factor: 1, 2
    • DM patient and high prevalence: 1
    • DM patient and patient population: 1
    • high prevalence and HZ high prevalence: 1
    • high prevalence and HZ prevalence: 1
    • high prevalence and molecular mechanism: 1
    • high prevalence and patient population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • HZ development and HZ prevalence: 1, 2
    • HZ high prevalence and HZ prevalence: 1